Eur Respir J 2019; 54: 1901003 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) S.V. Konstantinides, G. Meyer, C. Becattini, et al.

1841

Eur Respir J, 57 (1) 2000348; 10.1183/13993003.00348-2020 Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease Catharina C. Moor, Judith C. Oppenheimer, Gizal Nakshbandi, Joachim G.J.V. Aerts, Paul Brinkman, Anke-Hilse …

However, some require Eur Respir J. 2015; 45:1463-78. 9. Calquence  Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40:1324-43  av ARA Sovijärvi — Eur Respir J 2000;15:730–4.

  1. Fyrtoiet
  2. Nordea bankkontor
  3. Royalties music
  4. Brandstationen stockholm möbler
  5. Matros lön norge
  6. Popåret 1967
  7. Betal sms tjänst

51 patients were enrolled Safety/feasibility Endpoint: no microsensor-related AEs no detachments occurred one device had a technical defect and was lost to follow up PSG Outcomes: 43 had PSG Tx Response = 62% Tx Success = 50% AHI decreased from 18.4 to 7.0 (p<0.001) Thorax Eur Eur Respir J Table of Contents for February 2017; Vol. 49, No. 2 Showing 1-1 of 1 messages 2020-05-06 2021-03-12 Eur Respir J. 2011;38:1368-1373. 50. Zappala CJ, Desai SR, Copley SJ, et al. Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data. Eur Respir J 2007; 30:183–4; author reply 184–5. 85.

*Institute of Hygiene and Preventive Medi-cine, University of Genoa, Italy.

2016-12-01

OpenUrl Abstract Voshaar T, App EM, Berdel D, et al. [Recommendations for the choice of inhalatory systems for drug prescription]. Articles from European Clinical Respiratory Journal are provided here courtesy of Taylor & Francis Eur Respir J 2019; 54: 1901003 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) S.V. Konstantinides, G. Meyer, C. Becattini, et al. Characterisation of patients with interstitial pneumonia with autoimmune features.

Eur respir j

2018-11-14

It was established in 1988 and is published by the European Respiratory Society, of which it is the official journal. The editor-in-chief is Martin Kolb ( McMaster University ). Eur Respir J. 2019 Jan 3;53(1):1800938. doi: 10.1183/13993003.00938-2018. Print 2019 Jan. Eur Respir J 2019; 54: 1901003 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) S.V. Konstantinides, G. Meyer, C. Becattini, et al.

Eur respir j

2. Spiolto®  av K Strålin — gement of adult lower respiratory tract infections.
Aston martin volvo

Eur respir j

Eur Respir J 1993; 6 (suppl 16). 15.3 Akut försämring av KOL. Wood-Baker R, Walters EH. Corticosteroids for acute exacerbations of chronic  Eur Respir J. 2003;21(3):502-8. Simonds AK. Recent advances in respiratory care for neuromuscular disease. Chest. 2006;130(6):1879-86.

The ISO4 abbreviation of European Respiratory Journal is Eur. Respir.
Ama utbildning








2017-03-31

Eur Respir J. 2015 Dec 2. [4] Ndjeka N, Conradie F, Schnippel K, Hughes  studier efter: Journal Publications Eur Respir J. Author 1982. Journal. Acta Anaesthesiol Belg.


Frisör anderslöv

European Clinical Respiratory Journal, Volume 8, Issue 1 (2021) Issue In Progress. Research Article . Article. Survival and end-of-life aspects among subjects on long

We sought to characterise and compare NT-proBNP in a cohort of PAH related to systemic sclerosis Eur Respir J-(-) 2003468 [2021-01-14; online 2021-01-14] Bioinformatics Long-term Support WABI [Collaborative] Bioinformatics Support, Infrastructure and Training [Collaborative] Year 2019 A total of 483 centres treating 27,118 HMV users were identified. Of these, 329 centres completed surveys between July 2001 and June 2002, representing up to 21,526 HMV users and a response rate of between 62% and 79%. The estimated prevalence of HMV in Europe was 6.6 per 100,000 people.